CERO THERAPEUTICS HOLDINGS, INC. Operating Income
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Operating Income of -$3.85 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-14
- CERO THERAPEUTICS HOLDINGS, INC. operating income (loss) for the quarter ending 2026-06-30 was -$3.85M.
- CERO THERAPEUTICS HOLDINGS, INC. operating income (loss) for the quarter ending 2026-03-31 was -$4.85M.
- CERO THERAPEUTICS HOLDINGS, INC. operating income (loss) for the quarter ending 2025-09-30 was -$4.36M.
- CERO THERAPEUTICS HOLDINGS, INC. operating income (loss) for the quarter ending 2025-06-30 was -$4.72M.
- CERO THERAPEUTICS HOLDINGS, INC. operating income (loss) for fiscal 2023 was -$7.68M.
- CERO THERAPEUTICS HOLDINGS, INC. operating income (loss) for fiscal 2022 was -$2.91M.
| Period end | Operating Income (Loss) 1 month | Operating Income (Loss) 2 month | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 5 month | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 8 month | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 11 month | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.85M 10-Q · filed 2026-08-14 | -$8.69M 10-Q · filed 2026-08-14 | |||||||||||
| 2026-03-31 | -$4.85M 10-Q · filed 2026-05-15 | ||||||||||||
| 2025-09-30 | -$4.36M 10-Q · filed 2025-11-19 | -$9.09M derived: sum of 2 quarters · filed 2026-08-14 | -$14.04M 10-Q · filed 2025-11-19 | ||||||||||
| 2025-06-30 | -$4.72M 10-Q · filed 2026-08-14 | -$9.67M 10-Q · filed 2026-08-14 | |||||||||||
| 2025-03-31 | -$4.95M 10-Q · filed 2026-05-15 | ||||||||||||
| 2024-12-31 | -$15.30M 10-K · filed 2025-04-15 | ||||||||||||
| 2024-09-30 | -$4.40M 10-Q · filed 2025-11-19 | -$9.55M derived: sum of 2 quarters · filed 2025-11-19 | -$13.21M 10-Q · filed 2025-11-19 | ||||||||||
| 2024-06-30 | -$5.15M 10-Q · filed 2025-08-22 | -$8.80M 10-Q · filed 2025-08-22 | |||||||||||
| 2024-03-31 | -$3.65M 10-Q · filed 2025-05-15 | ||||||||||||
| 2024-02-13 | -$897.13K 10-Q · filed 2025-11-19 | ||||||||||||
| 2023-12-31 | -$1.12M derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-04-15 | -$2.66M derived: sum of 2 quarters · filed 2025-04-15 | -$5.07M derived: sum of 3 quarters · filed 2025-04-15 | -$7.68M 10-K · filed 2025-04-15 | -$2.93M 10-K · filed 2024-04-02 | ||||||||
| 2023-09-30 | -$1.54M 10-Q/A · filed 2024-11-20 | -$429.80K 10-Q · filed 2023-11-09 | -$3.95M derived: sum of 2 quarters · filed 2024-11-20 | -$6.55M 10-Q/A · filed 2024-11-20 | -$2.56M 10-Q · filed 2023-11-09 | -$7.68M derived: sum of 4 quarters · filed 2024-11-20 | |||||||
| 2023-06-30 | -$2.41M 10-Q · filed 2024-08-14 | -$1.54M 10-Q · filed 2023-08-14 | -$4.85M 10-Q · filed 2024-08-14 | -$2.13M 10-Q · filed 2023-08-14 | -$6.14M derived: sum of 3 quarters · filed 2024-08-14 | -$6.98M derived: sum of 4 quarters · filed 2024-08-14 | |||||||
| 2023-03-31 | -$2.44M 10-Q · filed 2024-05-17 | -$3.73M derived: sum of 2 quarters · filed 2024-05-17 | -$4.56M derived: sum of 3 quarters · filed 2024-05-17 | -$4.94M derived: sum of 4 quarters · filed 2024-05-17 | |||||||||
| 2022-12-31 | -$1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-02 | -$2.12M derived: sum of 2 quarters · filed 2024-04-02 | -$2.50M derived: sum of 3 quarters · filed 2024-04-02 | -$2.91M 10-K · filed 2024-04-02 | |||||||||
| 2022-09-30 | -$836.68K 10-Q · filed 2023-11-09 | -$1.21M derived: sum of 2 quarters · filed 2023-11-09 | -$1.62M 10-Q · filed 2023-11-09 | ||||||||||
| 2022-06-30 | -$376.58K 10-Q · filed 2023-08-14 | -$781.36K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |